Infliximab drug and antibody levels in patients with dermatological conditions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infliximab drug and antibody levels in patients with dermatological conditions

Published:2015-01-23 Issue:2 Volume:37 Page:320-326
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Elberdín L.,Outeda M.,Salvador P.,Paradela S.,Fernández-Torres R. M.,Iglesias R.,Fonseca E.,Martín I.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

http://link.springer.com/content/pdf/10.1007/s11096-014-0062-3.pdf

Reference30 articles.

1. Puig L, Carrascosa JM, Daudén E, Sánchez-Carazo JL, Ferrándiz C, Sánchez-Regaña M, et al. Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents. Actas Dermosifiliogr. 2009;100:386–413.

2. Mössner R, Schön MP, Reich K. Tumor necrosis factor antagonists in the therapy of psoriasis. Clin Dermatol. 2008;26:486–502.

3. Doty JD, Mazur JE, Judson MA, et al. Treatment of sarcoidosis with infliximab. Chest. 2005;127:1064–71.

4. White ES. Infliximab in sarcoidosis: more answers or more questions? Am J Respir Crit Care Med. 2006;174:732–3.

5. Foster EN, Nguyen KK, Sheikh RA, Prindiville TP. Crohn’s disease associated with Sweet’s syndrome and Sjögren’s syndrome treated with infliximab. Clin Dev Immunol. 2005;12:145–9.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between infliximab concentrations and clinical response in psoriasis: a prospective cohort study;Journal of Dermatological Treatment;2019-11-20

2. The impact of immunogenicity of TNFα inhibitors in autoimmune inflammatory disease. A systematic review and meta-analysis;Autoimmunity Reviews;2017-06

3. Positive correlation between etanercept concentration and the decrease in Psoriasis Area and Severity Index scale value;International Journal of Clinical Pharmacy;2016-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3